日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Industries

Pharma association issues report on innovative drugs

By Liu Zhihua | chinadaily.com.cn | Updated: 2021-04-21 17:44
Share
Share - WeChat
The Executive Committee of the Research & Development-based Pharmaceutical Association Committee under the China Association of Enterprises with Foreign Investment held an event on Tuesday to release a report on the innovative pharmaceutical industry and its role in the implementation of the Healthy China 2030 initiative. [Photo provided to chinadaily.com.cn]

A total of 200 innovative drugs have been approved in China over the past five years, among which many have been included in public-funded medical insurance programs, according to a recent report by the Executive Committee of the Research & Development-based Pharmaceutical Association Committee under the China Association of Enterprises with Foreign Investment.

Focusing on the innovative pharmaceutical industry and its role in the implementation of the Healthy China 2030 initiative, the report said about 33 percent of innovative drugs approved in the past five years are tumor treatments, and about 80 percent of the drugs, or 156 titles, are from multinational pharmaceutical companies.

The innovative drugs registered by multinational pharmaceutical companies have also showed more diversity in the past five years, as the share of tumor treatments has dropped to 33 percent from 47 percent in the period from 2010 to 2015, while more drugs for diseases related to the nervous system, digestion and the cardiovascular and respiratory systems have been registered.

Yang Ying, vice-president of Worldwide Business Development Asia at US-based pharmaceutical company Pfizer, said foreign pharmaceutical enterprises see China not only as an important market, but also an important investment destination for both commercialization and research and development.

As Chinese enterprises show increasing innovation capabilities, there are more cooperation opportunities for foreign and domestic enterprises in pharmaceutical industry, she said.

However, high costs and patients' lack of access to innovative drugs still remain a problem for the innovative pharmaceutical industry in China, according to the report.

Innovative drugs only account for about 9 percent of the total pharmaceutical market in China, the world's second-largest pharmaceutical market in the world, while in other G20 member countries the figure is all above 20 percent, and in developed countries such as the United States, Japan and Germany, the figure is more than 50 percent.

Kang Wei, managing director of RDPAC, suggested promoting the development of commercial insurance to increase the accessibility of innovative drugs and thus better meet Chinese patients' clinical demands.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 亚洲一区二区欧美日韩 | 日韩美女中文字幕 | 中文字幕在线免费观看 | 国产一极毛片 | 九九九热视频 | 五月丁香啪啪. | 日本高清不卡在线 | 五月激情六月 | 日韩在线不卡一区 | 午夜电影网址 | 伊人a.v在线| 国产精品第一区 | 亚洲欧美一区二区三区另类 | 欧美日韩亚洲国产 | 欧洲一级毛片 | 天天舔天天舔 | 久久综合色婷婷 | 久久成人精品 | 女生羞羞网站 | se就是色94欧美setu | 国产WW久久久久久久久久 | 国产亚洲精品久久久久婷婷图片 | 亚洲一区在线免费观看 | 亚洲午夜精品国产电影在线观看 | 亚洲欧美日韩精品久久亚洲区 | 看免费大片| 亚洲国产精久久久久久久 | 99在线观看精品 | 久草免费在线观看 | 一区二区三区日韩精品 | 狠狠干成人 | av免费在线观看网站 | 久久国产成人福利播放 | 日韩日b视频 | 久草在线网址 | 欧美在线视频一区二区 | 欧美a级在线观看 | 黄色国产精品 | 在线一级片 | 国产精品1区2区3区 二区国产 | 91社区影院|